Clinical trial

Androgen Deprivation Therapy in Treating Patients With Prostate Cancer

NCT00110162

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention antiandrogen therapy Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention releasing hormone agonist therapy Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention orchiectomy Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Androgen Deprivation Therapy in Treating Patients With Prostate Cancer

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2004-10-01

PhasePHASE3

Conditions

Prostate Cancerverified · MONDO: prostate cancer

Interventions

antiandrogen therapyDRUG

releasing hormone agonist therapyDRUG

orchiectomyPROCEDURE

Sponsors & collaborators

Peter MacCallum Cancer Centre, Australialead sponsor

Mapped research locations

MelbourneVictoria, Australia1 SydneyNew South Wales, Australia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00110162 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.